Real-time enrollment status for this pancreatic ductal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 11:11 PM UTC
| NCT Number | NCT06831136 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Ductal Adenocarcinoma |
| Phase | PHASE2 |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | The University of Texas Health Science Center, Houston |
| Last Updated on CT.gov | September 10, 2025 (Sep 10, 2025) |
As of August 31, 2026: Clinical trial NCT06831136 is currently recruiting participants. This phase2 study for pancreatic ductal adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by The University of Texas Health Science Center, Houston. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06831136 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06831136 was last updated Sep 10, 2025 (September 10, 2025). HelloStudys verifies this status automatically.